Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
2000 1
2002 1
2010 1
2011 3
2012 1
2016 1
2017 3
2018 2
2019 1
2020 2
2022 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
Anastasopoulou S, Harila-Saari A, Als-Nielsen B, Eriksson MA, Heyman M, Johannsdottir IM, Marquart HV, Niinimäki R, Pronk CJ, Schmiegelow K, Vaitkeviciene G, Thastrup M, Ranta S. Anastasopoulou S, et al. Among authors: johannsdottir im. Pediatr Blood Cancer. 2022 Jul;69(7):e29745. doi: 10.1002/pbc.29745. Epub 2022 Apr 30. Pediatr Blood Cancer. 2022. PMID: 35488712
Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL).
Panagopoulos I, Andersen K, Johannsdottir IMR, Tandsæther MR, Micci F, Heim S. Panagopoulos I, et al. Among authors: johannsdottir imr. Cancer Genomics Proteomics. 2024 Jan-Feb;21(1):1-11. doi: 10.21873/cgp.20424. Cancer Genomics Proteomics. 2024. PMID: 38151288 Free PMC article.
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.
Anastasopoulou S, Nielsen RL, Als-Nielsen B, Banerjee J, Eriksson MA, Helenius M, Heyman MM, Johannsdottir IM, Jonsson OG, MacGregor S, Mateos MK, Mayoh C, Mikkel S, Myrberg IH, Niinimäki R, Schmiegelow K, Taskinen M, Vaitkeviciene G, Warnqvist A, Wolthers B, Harila-Saari A, Ranta S. Anastasopoulou S, et al. Among authors: johannsdottir im. Haematologica. 2022 Oct 1;107(10):2318-2328. doi: 10.3324/haematol.2021.280016. Haematologica. 2022. PMID: 35354251 Free PMC article.
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia.
Dam M, Centanni M, Friberg LE, Centanni D, Karlsson MO, Stensig Lynggaard L, Johannsdottir IM, Wik HS, Malmros J, Vaitkeviciene GE, Griskevicius L, Hallböök H, Jónsson ÓG, Overgaard U, Schmiegelow K, Hansen SN, Heyman M, Albertsen BK. Dam M, et al. Among authors: johannsdottir im. Leukemia. 2024 Apr;38(4):712-719. doi: 10.1038/s41375-024-02153-6. Epub 2024 Jan 29. Leukemia. 2024. PMID: 38287133 Free PMC article.
Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort study.
Anastasopoulou S, Heyman M, Eriksson MA, Niinimäki R, Taskinen M, Mikkel S, Vaitkeviciene GE, Johannsdottir IM, Myrberg IH, Jonsson OG, Als-Nielsen B, Schmiegelow K, Banerjee J, Ranta S, Harila-Saari A. Anastasopoulou S, et al. Among authors: johannsdottir im. Eur J Paediatr Neurol. 2020 Jul;27:72-77. doi: 10.1016/j.ejpn.2020.04.004. Epub 2020 Apr 18. Eur J Paediatr Neurol. 2020. PMID: 32340855
Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
Anastasopoulou S, Eriksson MA, Heyman M, Wang C, Niinimäki R, Mikkel S, Vaitkevičienė GE, Johannsdottir IM, Myrberg IH, Jonsson OG, Als-Nielsen B, Schmiegelow K, Banerjee J, Harila-Saari A, Ranta S. Anastasopoulou S, et al. Among authors: johannsdottir im. Pediatr Blood Cancer. 2019 May;66(5):e27594. doi: 10.1002/pbc.27594. Epub 2018 Dec 27. Pediatr Blood Cancer. 2019. PMID: 30592147
18 results